Clinical Trial Update: Repository Corticotropin Injection in Keratoconjunctivitis Sicca [Phase 4]

View source ↗

Summary

A Phase 4 trial of repository corticotropin injection for keratoconjunctivitis sicca has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratoconjunctivitis Sicca

Drugs mentioned

• repository corticotropin injection (repository corticotropin injection)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Keratoconjunctivitis Sicca | Phase 4 | Status: WITHDRAWN